Results 181 to 190 of about 73,504 (266)

Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. <i>Vaccines</i> 2024, <i>12</i>, 974. [PDF]

open access: yesVaccines (Basel)
Feemster K   +8 more
europepmc   +1 more source

Safety and coverage of Pneumosil pneumococcal polysaccharide conjugate vaccine (10-valent PCV) in a camp for internally displaced persons in Somaliland

open access: hybrid
Catherine R. McGowan   +15 more
openalex   +1 more source

Reports of Injection Site Necrosis After 23-Valent Pneumococcal Vaccine Use.

open access: yesJAMA Intern Med, 2023
Day B   +3 more
europepmc   +1 more source

Outpatient Visits and Antibiotic Use Due to Higher-Valency Pneumococcal Vaccine Serotypes. [PDF]

open access: yesJ Infect Dis
King LM   +7 more
europepmc   +1 more source

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies

open access: yes
Cheliotis KS   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy